Obscure gastrointestinal bleeding caused by congenital enteropathy in a Chinese young child-a case report

Background SLCO2A1 was recently reported to cause nonspecific ulcers at small bowel, it was named as chronic enteropathy associated with SLCO2A1 (CEAS). It was rarely reported beyond the Japanese population. Case presentation A 4-year-5-month old girl presented with intractable anemia since 1-year-3-month. Her stool occult blood test was positive and the result of esophagogastroduodenoscopy and colonoscopy were normal. She was considered as obscure gastrointestinal bleeding. The magnetic resonance enterography and ultrasound of small intestinal revealed segmental thickening of small bowel. The capsule endoscopy detected ulcers, erosion and slightly stenosis near the site of junction of jejunum and ileum. She was considered chronic non-specific multiple ulcers of the small intestine and was advised to have whole exon sequencing. She was treated with exclusive enteral nutrition and iron supplement for two months. However, she was not responsive to this treatment, then she had three doses of infliximab. At the same time, the next-generation sequencing of this patient revealed two novel compound heterozygous mutations in SLCO2A1. She was diagnosed with CEAS and was treated with oral mercaptopurine. Her hemoglobin level was stable and the serum albumin level was slightly decreased during the follow up. Conclusion CEAS may present as nonspecific small bowel ulcers, and misinterpret as small bowel Crohn’s disease. Genetic tests may help with the precise diagnosis of small bowel ulcers.

parents and sister didn't have anemia. Her blood routine test showed the hemoglobin level was 96 g/L, mean corpuscular volume (MCV) was 79.9 fL, mean corpuscular hemoglobin (MCH) was 24.9 pg, mean corpuscular hemoglobin concentration was (MCHC) 312 g/L, which indicated a hypochromic microcytic anemia. She was referred to the hematologist, and the results of etiology tests for anemia were showed in the Table 1. High resolution melting did not detect hot mutations of thalassemia and the bone marrow morphology test revealed hypochromic microcytic anemia. During the three years, she accepted iron supplementation intermittently. Her hemoglobin level was ranging from 67 to 120 g/L.
She was referred to a gastroenterologist because the stool occult blood test was positive sometimes. She had no history of taking aspirin or any other medicine. Her serum albumin level was 34 g/L. She was diagnosed with gastrointestinal bleeding, and started the initial laboratory tests ( Table 1). The EGD and the colonoscopy didn't detect ulcer or inflammation. The results of magnetic resonance enterography (MRE) and the ultrasound revealed segmental thickening of small intestinal wall, with the wall thickness of 0.46 cm and mainly involved the mucosal and submucosal of small intestinal. Capsule endoscopy didn't reach the terminal ileum during the working time and a retention was observed. It revealed superficial ulcers and erosion at the location of stricture near the junction of jejunum and ileum (Fig. 1). She had double balloon endoscopy (DBE) through both mouth and anus. However, the DBE didn't reach the location of stricture, and it did not reveal any other lesions. Based on the small bowel ulcers and stricture, anemia, mild hypoalbuminemia, and obviously increased fecal calprotectin, she was initially diagnosed as chronic non-specific multiple ulcers of the small intestine (CNSU) and very early onset small bowel intestinal Crohn's disease was the main differential diagnosis. She was advised to have whole exome sequencing because of early disease onset and suspecting congenital disease. She was treated with exclusive enteral nutrition (EEN) and iron supplement after discussing with her parents.
She received EEN and iron supplement for eight weeks. The hemoglobin level was ranging between 90 and 107 g/L, and the repeated fecal calprotectin was still higher than 1800 ng/g. She received infliximab. However, she still had anemia and hypoalbuminemia after three doses of infliximab.
Immunohistochemical analysis of SLCO2A1 protein SLCO2A1 expressions in the duodenal tissues were positive in patient and control (Fig. 3). The control with the complaint of intermitted abdominal pain for one year, and finally diagnosed with primary dysmenorrhea. CD31 immunostaining indicated the vascular endothelial cells of the capillary vessels in the mucosa of patient and control.

Follow up
SLCO2A1 mutation is related to the chronic nonspecific multiple ulcers of the small intestine. Combined with her history and character of her endoscopy findings, she was diagnosed as CEAS. There was no effective treatment according to the reported literatures about the treatment for CEAS. Some patients were responsive to

Discussion and Conclusion
OGIB can be caused by small bowel ulcers, the ulcers can be interpreted as mucosal inflammation, vasculitis, druginduced or nonspecific ulcers caused by inherited diseases.
With the exploration to the last terminal of small intestinal by using of DBE and CE, increasing small intestinal diseases were recognized, among them there was a group of diseases presenting as nonspecific multiple ulcers in the small intestinal. It is identified with mutation of gene SLCO2A1 and is also called CEAS [2]. We searched the keywords of "CEAS", "nonspecific multiple ulcers" or "SLCO2A1 and enteropathy" in the PUBMED and reviewed the literatures. So far as we know, all of the patients reported in the literatures diagnosed with CEAS were almost Japanese, except two patients recently reported by Korea [3] and Chinese [4]. Thus, we hypothesized that CEAS was underestimated or was not recognized in Chines patients. In this study, we reported a young child presented with OGIB caused by compound heterozygous mutations of SLCO2A1. This young child was mainly presented with anemia, and  A national study in Japan [5] including 65 CEAS patients identified 46 patients with SLCO2A1 mutations at 11 sites. This disease predominantly occurs in woman, the male vs female ratio was 1:2.5, and it tends to affect the adolescents, with disease onset at 16.5 years (range, 1-69 years). There was only one literature focused on the child onset CEAS which reported four cases of CEAS children, and two patients were have disease onset within 2 years old [6]. The clinical features of these patients were mainly anemia 45 (98%), abdominal pain 18 (39%) and edema 11 (24%) [5]. CEAS ulcers are characterized by multiple, circular or eccentric oblique, shallow lesions with discrete margins [7]. In all the CEAS patients, the ileum is most frequently involved (98%-100%) [5], and the terminal ileum is not involved. While for small bowel Crohn's disease, terminal ileum is the most common frequently involved. Patients with SLCO2A1 mutation has negative immunohistochemical staining for SLCO2A1 while the patient reported here was positive. The immunohistochemical staining is useful in the diagnosis of CEAS. However, patients with deleterious mutations of SLCO2A1 but not truncated mutation could not detect by immunohistochemical study [8]. Our patient may have the same condition.
There were several hot mutations reported in the Japanese population. Among the detected SLCO2A1 mutations, a splicing mutation at intron 7 (c.940 + 1G > A; rs765249238) was the most frequently observed among CEAS patients, with 54% of mutation allele frequency [5]. Our patient had disease onset as early as one year and three months, and harbored two novel mutations, which were not reported in Japanese population. Mutation of c.1808 g > C, resulting amino acid changes from arginine to proline, the frequency of this mutation is 0.000024 among the normal population. Mutation of c.1814 + 2 T > G, causes splicing mutation at terminal 5 which resulting amino acid change. According to the American College of Medical Genetics and Genomics the variant of c.1808 g > C was identified as variants of unknown significance and the variant of c.1814 + 2 T > G was identified as Likely Pathogenic. The hot mutations in different genetic background maybe different.
SLCO2A1 is also identified as a causal gene of primary hypertrophic osteoarthropathy (PHO) in 2012 [9]. Since then, many PHO patients were reported to have mutations of SLCO2A1 [10][11][12]. Interestingly, among the PHO patients with SLCO2A1 mutations over 50% percent patients had watery diarrhea and over 20% patients had anemia [13]. Unfortunately, there were no reports about the intestinal enteropathy in PHO patients. CEAS accompanied with PHO were previously reported [14][15][16]. Since SLCO2A1 is shared with PHO, the major clinical manifestations of PHO, such as digital clubbing, periostosis, pachydermia were commonly observed in CEAS [5]. However, the PHO was more common observed in male while the CEAS was dominant in female. The relationship between CEAS and PHO are not clear. Our patient reported here didn't show any typical features of PHO so far. In conclusion, patients with nonspecific small intestinal ulcers with intractable anemia or hypoproteinemia should suspect CEAS. Although CEAS was rarely reported outside Japanese population, PHO was constantly reported. It may be under estimated in other population.